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The surface of mesoporous silica nanoparticles (MSNs) has been modiﬁed for enhancing their cellular
uptake, cell targeting, bioimaging, and controlled drug release. For this purpose, covalent anchorage on
the silica surface was predominantly exploited with a wide range of bioactive molecules. Here, we
describe a facile self-assembly method to prepare a hybrid peptide silica system composed of octyl-
modiﬁed mesoporous silica nanoparticles (MSNs) and peptide amphiphiles (PAs). The hydrophobic
organosilane surface of mesoporous silica was coated with amphiphilic peptide molecules. The peptide
functionalized particles exhibited good cyto-compatibility with vascular smooth muscle and vascular
endothelial cells. The peptide coating also improved the cellular uptake of particles up to 6.3 fold, which
is promising for the development of highly eﬃcient MSN based theranostic agents.Introduction
Mesoporous silica nanoparticles (MSNs) have high specic
surface area, large pore volume, controlled particle size and
morphology, and low inherent toxicity. They are promising
platforms for theranostic applications.1–3 Previously, in vitro
studies of MSNs demonstrated that these materials can be used
as drug delivery and cell marking agents.4–6 However, it was
observed that the bare silica surface (containing reactive silanol
groups) can cause aggregation of particles and opsonization in a
biological environment, and nonspecically interact with the
membrane of several cell types, which results in poor biocom-
patibility and pharmacokinetics for in vivo applications.7–11
Modication of the reactive MSN surface with polymers12–15
(e.g. PEG and zwitterionic copolymers), small molecules10,16 (e.g.
phosphonate) or biomolecules17–19 (e.g. antibodies, peptides,
lipid bilayers, DNA and aptamers) has been proved to be an
eﬀective way to improve the biocompatibility of particles as well
as the eﬃciency of MSN based therapies. In particular, short
peptide chains have attracted a great deal of attention in recent
years because of their tunable functionality, biodegradability,
and relative ease of synthesis.20–22 It has been shown that short
peptide sequences (e.g. RGD and IL-13) can be used for targeting
nanoparticles to specic cancer cell lines.22–26 In addition toUNAM), Bilkent University, 06800 Ankara,
.tr; atekinay@unam.bilkent.edu.tr; Fax:
nology, Bilkent University, 06800 Ankara,
tion (ESI) available. See DOI:
–2174targeting properties, some peptide sequences (e.g. TAT peptide)
demonstrated cell penetrating and endosomal escape proper-
ties.27–29 Also, the biodegradability of peptides makes them
suitable for being utilized as stimuli responsive gatekeepers in
controlled drug release30,31 and linkers in FRET based
diagnostics.32–34
Conventionally, peptides are covalently attached to the
silica surface by using additional cross-linking reagents and
troublesome synthetic methods, which results in poor
surface graing density and costly synthesis of functional-
ized materials.24,30,35 In this work, we demonstrate a simple
and cost-eﬀective self-assembly approach to prepare peptide
functionalized MSNs, as a promising alternative for covalent
attachment methods.13 Our method is based on the sponta-
neous attachment of peptide amphiphiles (PAs) to the octyl
modied MSN surfaces in aqueous media through hydro-
phobic interactions between octyl groups of MSNs and alkyl
chains of PAs (Scheme 1a). We selected two model PA mole-
cules, with diﬀerent charges, to functionalize MSNs. The
glutamic acid and lysine residues on the PAs provide negative
and positive charges to the hybrid system, respectively
(Scheme 1b). The unmodied MSNs were synthesized in
order to compare with peptide functionalized MSNs. The
eﬀect of peptide functionalization on cell viability and
uptake was investigated by using human umbilical vein
endothelial cells (HUVECs) and a vascular smooth muscle
cell line (A10). All of the MSN systems demonstrated good
cyto-compatibility with both cell lines up to a concentration
of 200 mg mL1. Interestingly, we observed a remarkable
increase (1.8 to 6.3 fold) in the cellular uptake of peptide
functionalized MSNs compared to bare MSNs depending on
the surface charge of PAs as well as the cell type.This journal is © The Royal Society of Chemistry 2014
Scheme 1 (a) Schematic presentation of the preparation of peptide
functionalized MSNs. (b) Chemical structures of the peptide amphi-
phile molecules used in this study.
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View Article OnlineExperimental section
Materials
9-Fluorenylmethoxycarbonyl (Fmoc) and tert-butoxycarbonyl (Boc)
protected L-amino acids, [4-[a-(20,40-dimethoxyphenyl) Fmocami-
nomethyl]phenoxy]acetamidonorleucyl-MBHA resin (Rink amide
MBHA resin), and 2-(1H-Benzotriazol-1-yl)-1,1,3,3 tetramethy-
luronium hexauorophosphate (HBTU) were purchased from
NovaBiochem and ABCR. Tetraethyl orthosilicate (TEOS), octyl-
triethoxysilane (OTS), aminopropyl triethoxysilane (APTES),
sodium hydroxide, and lauric acid were purchased from Merck.
Fluorescein isothiocyanate (FITC), cetyltriammoniumbromide
(CTAB) and ethanol were purchased from Sigma-Aldrich. Meth-
anol was purchased from Carlo-Erba. Tetrahydrofuran (THF) was
purchased from Labkim. All reagents and solvents were used as
provided. Cell culture chemicals were purchased from Gibco, Life
Technologies.
Synthesis of MSNs and OMSNs
In order to synthesize FITC labelled OMSNs, 2 mg of FITC was
conjugated to 10 mL of APTES in 1 mL of ethanol by gently
stirring for 24 h. Then, 200 mg of CTAB and 6 mg of F127 were
dissolved in 96 mL of deionized water and 0.7 mL of 2 M NaOH
was added. The solution was heated to 80 C under vigorous
stirring (600 rpm). Aer the temperature of the reaction mixture
was stabilized at 80 C, 1 mL of TEOS and FITC solution was
rapidly added. Aer 75 min, 0.2 mL of OTS was dissolved in
10 mL THF and slowly added to the reaction mixture in order to
form an octyl-containing shell. The mixture was further stirred
for 90 min. Finally, the particles were collected by centrifuga-
tion at 9000 rpm and washed with methanol twice. Surfactant
extraction was performed by stirring the particles in 50 mL of
20 g L1 ethanolic ammonium nitrate at 60 C for 1 h. This
treatment was repeated twice to ensure complete surfactantThis journal is © The Royal Society of Chemistry 2014removal. Particles were washed with ethanol twice and dried at
50 C overnight. MSNs were synthesized by using the same
parameters with the exception of OTS addition.
Synthesis and characterization of peptide amphiphile
molecules
The positively charged peptide amphiphile (K-PA) was con-
structed on MHBA Rink Amide (0.59 mmol g1 loading) resin,
and the negatively charged peptide amphiphile (E-PA) was con-
structed on Fmoc-Glu-Wang (0.64 mmol g1 loading) resin. All
amino acid couplings were performedwith 2 equivalents of Fmoc
protected amino acid, 1.95 equivalents of HBTU and 3 equiva-
lents of N,N-diisopropylethylamine (DIEA) in dimethylforma-
mide (DMF) for 2 h. Fmoc removals were performed with 20%
piperidine–DMF solution for 20 min. The cleavage of the
peptides from the resin was carried out with a mixture of tri-
uoroacetic acid (TFA)–triisopropylsilane (TIS)–water in the ratio
of 95 : 2.5 : 2.5 for 2 h. Excess TFA was removed by rotary evap-
oration. The remaining viscous peptide solution was treated with
ice-cold diethyl ether and the resulting white pellet was freeze-
dried. The peptide amphiphiles were identied and analyzed by
reverse phase HPLC on an Agilent 6530 accurate-Mass Q-TOF LC/
MS equipped with an Agilent 1200HPLC. A phenomenex Luna 3m
C8 100A (50  3.00 mm) column as the stationary phase and
water–acetonitrile gradient with 0.1% volume of formic acid as
the mobile phase were used to identify the positively charged
peptide amphiphile. For the negatively charged peptide amphi-
phile, an Agilent Zorbax Extend-C18 (2.1 50mm) column as the
stationary phase and water–acetonitrile gradient with 0.1%
volume of ammonium hydroxide as the mobile phase were used.
The positively and negatively charged peptide amphiphiles were
puried by using a 1200 Agilent HPLC on a Zorbax 300SB C8 (21.2
 150 mm) PrepHT and a Zorbax-Extend C18 (21.2  150 mm)
PrepHT column, respectively.
Coating the OMSN with peptide amphiphiles
While 14 mg of each peptide amphiphile was sonicated in 12
mL deionized water, 2 mg of OMSNs was slowly added to the
system. Peptide amphiphiles and OMSNs were mixed in a
weight ratio of 1 : 7. They were sonicated and vortexed for 3 h at
room temperature. The solution was centrifuged at 5000 rpm.
Aer all portions were concentrated by centrifugation, they were
rinsed with water and centrifuged twice.
Characterization of the particles
The hydrodynamic size and zeta potential of the particles were
measured by using a Zetasizer. A Malvern Nanosizer/Zetasizer
nano-ZS ZEN 3600 (Malvern Instruments, USA) instrument was
used for the analysis. Measurements were performed in glass
cuvettes and repeated at least three times. TEM images were
obtained using a FEI Tecnai G2 F30 TEM at 300 kV. Samples for
imaging were prepared by diluting PA coatedMSNs to 0.01% (w/v)
on a 200-mesh copper TEMgrid for 5minwithout staining and air
dried. Fluorescence spectra of the particles were recorded using a
Varian Eclipse spectrophotometer with an excitation wavelength
of 488 nm. FTIR spectra of particles and PAs were collected byJ. Mater. Chem. B, 2014, 2, 2168–2174 | 2169
Fig. 1 (a) Photograph showing the water dispersion of OMSNs before
and after coating with peptide amphiphiles and (b) photographs of
MSN dispersion in water.
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View Article Onlineusing an FTIR spectrometer (Vertex 70, Bruker). Thermogravi-
metric analyses (TGA) were performed with a Q500 (TA Instru-
ments). The temperature was increased from room temperature
to 800 C with a rate of 20 C min1 under nitrogen gas.
Cell culture experiments
Viability and uptake experiments were performed by using
human umbilical vein endothelial cells (HUVECs) and A10 rat
aortic smooth muscle cells (ATCC® Cat# CRL-1476™). HUVECs
were donated by Yeditepe University, Istanbul, Turkey. HUVECs
were puried as described36 and characterized by staining with
CD34, CD31, and CD90 surface markers. These cells were found
to be positive for CD31 and CD34 but negative for CD90. A10 and
HUVEC cells were cultured in 75 cm2 polystyrene cell culture
asks with standard medium, containing Dulbecco's modied
eagle medium (DMEM) with 10% fetal bovine serum (FBS), and
1% penicillin–streptomycin and passaged at cell conuency
between 80 and 90% using trypsin–EDTA. In all experiments,
particles were administered in serum free medium (1% peni-
cillin–streptomycin containing DMEM) to avoid any inuence of
serum proteins on the uptake mechanism.
Cell viability tests
The cell viability assay was performed using Alamar Blue Assay
(Invitrogen). 5000 cells per well (HUVECs or A10) were seeded
on a 96-well plate in 100 mL of standard medium. Aer 24 h, the
medium was removed and 100 mL of serum free medium was
added. 25 mL of freshly prepared nanoparticle solutions in water
at diﬀerent concentrations were administered to have nal
concentrations of 200, 100, 50, and 10 mg mL1. For cell viability
tests, cells were exposed to particles for 4 h, then the medium
was changed to standard medium and the cells were further
incubated for 20 h. Then, Alamar Blue reagent diluted to 10% in
DMEM was added. Aer 3 h, uorescence at 570/612 nm (Ex/
Em) was measured using a microplate reader (SpectraMax, M5).
Cellular uptake analyses
13mm glass coverslips were placed in 24-well plates and 4 104
cells (HUVECs or A10) in standard medium were seeded in each
well. Aer 24 h, the medium was discarded, and 400 mL of
serum free medium was added to each well. 100 mL of bare or
functionalized MSNs were administered to have a nal
concentration of 200 mg mL1 MSNs. Aer 4 h, the medium was
exchanged to standard medium. Aer 20 h, the cells were
washed with PBS several times and xed with 4% para-
formaldehyde for 15 min. Then, the cells were permeabilized
with 0.1% TritonX-100 (Sigma-Aldrich) for 12 min and actin
proteins were stained with Phalloidin-TRITC (Sigma-Aldrich)
for 20 min. Coverslips were mounted on slides with Antifade
(Invitrogen). Samples were visualized with a laser scanning
confocal microscope (Zeiss, LSM 510).
Flow cytometry analysis
1  105 HUVECs or A10 cells per well were seeded in 6 well
plates in standard medium. The medium was discarded aer2170 | J. Mater. Chem. B, 2014, 2, 2168–217424 h and 1600 mL of serum free medium was added to each well.
400 mL of bare or functionalized MSNs were administered to
have a nal concentration of 200 mg mL1 MSNs. Aer 4 h, the
medium was changed to standard medium and the cells were
incubated for 20 h, then washed with PBS and trypsinized. The
cells were collected by centrifugation, washed twice with PBS,
resuspended in 1 mL PBS and kept on ice before analysis. An
FITC channel was used to analyze the MSN uptake using a ow
cytometer (BD, FACS Aria III). Non-treated cells were used as the
control. Student's t-test was applied to all datasets and a p value
of less than 0.05 was accepted to be statistically signicant.Results and discussion
Synthesis and characterization of peptide functionalized
MSNs
Octyl modied water insoluble MSNs (OMSNs) were synthesized
according to our previous reports13,37 by using a one-pot
respective condensation method.38 Tetraethyl orthosilicate
(TEOS) molecules were condensed under basic conditions and
initial MSNs were formed. Then, octyl triethoxysilane (OTS)
molecules were added to the reaction mixture to coat the MSNs
with a hydrophobic octyl layer. The uorescein isothiocyanate
(FITC) molecules were conjugated to the MSNs in the rst step
of the synthesis to track the uptake of particles by using
confocal imaging and ow cytometry methods.16 Successful
conjugation of FITC to the silica network was demonstrated by
using uorescence spectroscopy, where emission bands of FITC
molecules were clearly observed (ESI,† Fig. S1). Bare MSNs were
prepared for control experiments under the same experimental
conditions without the OTS addition. Peptide amphiphiles were
synthesized by solid phase peptide synthesis method based on
orthogonal protection and veried by liquid chromatography
and mass spectrometry (ESI,† Fig. S2 and S3).
OMSNs were coated with peptide amphiphile molecules by
simple sonication in E-PA or K-PA solutions (Fig. 1a). As-
prepared OMSNs are insoluble in water (Fig. 1a, le) because
their surface is covered with hydrophobic octyl groups. Aer the
addition of PA solution and ultrasonication, PA molecules self-
assemble on the OMSNs due to hydrophobic interactions
between alkyl chains of both OMSNs and PAs (Scheme 1a).
Functionalization with peptide amphiphiles renders the MSNsThis journal is © The Royal Society of Chemistry 2014
Fig. 3 FTIR spectra (a) and TGA spectra (b) of particles and peptide
amphiphiles, respectively.
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View Article Onlinewater dispersible by providing either positively or negatively
charged water soluble moieties on their surfaces. Photographs
of MSNs dispersed in water are shown in Fig. 1b. Both disper-
sions have light green color due to the covalently conjugated
FITC molecules. Fig. 2 shows the TEM images of the particles.
Bare MSNs exhibited an MCM-41 type highly ordered hexagonal
porous structure (Fig. 2a). On the other hand, for OMSNs, a
randomly porous thin shell was observed over an MCM-41 type
porous core (Fig. 2b) which is in accordance with our previous
work.13 Aer coating the OMSNs with E-PAs, a thin organic layer
was observed around the particles (Fig. 2c). In addition, a TEM
image of K-PA peptide coated OMSNs is provided in the ESI†
(Fig. S4).
The formation of a peptide coating over OMSNs was further
proved by using FTIR and TGA methods. Fig. 3a shows the FTIR
spectra of the particles. The –CH peaks between 2800 cm1 and
3000 cm1 were observed in the spectrum of OMSNs indicating
the successful octyl modication. These absorption bands
became stronger for PA modied particles (E-OMSNs and
K-OMSNs) due to the –CH bonds of the PAs. In addition, new
absorption bands between 1400 cm1 and 1800 cm1 appeared,
which are in good agreement with FTIR spectra of the PAs. The
amide I (1600–1690 cm1, C]O stretching) and amide II (1480–
1575 cm1, CN stretching, NH bending) bands of PAs were
observed for PA functionalized MSNs. Another C]O stretching
vibration was also observed for glutamic acid containing
particles at around 1725 cm1 which corresponds to the side
chain of the glutamic acid.
Fig. 3b shows the TGA analysis of the particles. For MSNs, a
small weight loss of 7.8% was observed between 100 C and
800 C due to the dehydroxylation of the silica surface.39 The
weight loss increased to 11.9% for OMSNs and most of the
weight loss occurred at around 500 C indicating the decom-
position of octyl moieties.13 For E-OMSNs and K-OMSNs large
weight loss values of 19.6% and 32.5% were recorded, respec-
tively. Also, two sharp decreases were observed in the spectra of
peptide coated particles around 400 C and 500 C, which
correspond to the decomposition of PAs and octyl groups,
respectively. For bare peptide amphiphiles, almost all weight
was lost at 800 C. Based on the TGA results, we calculated
graing densities of the PA molecules on the OMSN surfaces
(see ESI† for details).40,41 The graing densities of E-OMSNs and
K-OMSNs were 0.94 and 2.95 PA nm2, respectively, indicating
that the surface of OMSNs was densely covered by the peptide
molecules. A higher graing density of K-OMSNs was observed
due to the electrostatic interactions between positively chargedFig. 2 Characterization of the mesoporous silica nanoparticles. TEM
images of (a) MSNs, (b) OMSNs and (c) E-OMSNs.
This journal is © The Royal Society of Chemistry 2014K-PAs and unreacted surface silanol groups of OMSNs. Particle
sizes of the MSNs and OMSNs were calculated to be 100 nm and
104 nm, respectively from the TEM images (Table 1). The 4 nm
increase in the particle size aer octyl addition shows the 2
nm shell formation around the particles. Hydrodynamic sizes of
the MSN, E-MSN and K-MSN were measured by using the
dynamic light scattering technique (Table 1 and ESI,† Fig. S5).
The OMSNs are water insoluble and it is not possible to
measure their hydrodynamic size. Hydrodynamic sizes of the
peptide coated particles are slightly larger (around 40 nm) than
their primary particle sizes (size of OMSNs) due to the slightTable 1 Physical properties of bare, octyl modiﬁed and peptide
functionalized MSNs
Sample TEM size (nm) DLS size (nm) Zeta potential (mV)
MSNs 99.8  20.7 166.5  8.0 36.6  1.1
OMSNs 104.3  21.5 N/A N/A
E-OMSNs N/A 143.8  19.8 38.0  0.8
K-OMSNs N/A 145.2  1.6 25.1  0.7
J. Mater. Chem. B, 2014, 2, 2168–2174 | 2171
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View Article Onlineaggregation in aqueous media for these particles. On the other
hand, aggregation becomes more pronounced for bare MSNs
with a 67 nm diﬀerence between hydrodynamic and primary
particle sizes. This diﬀerence could be explained by the fact that
two diﬀerent techniques, TEM and DLS, were used for the
measurements. While dried samples were used for TEM
imaging, the hydrodynamic size of particles was measured
using DLS where interactions with solvent molecules are also
taken into account. The surfaces of the particles were charac-
terized by measuring their zeta potentials (Table 1). The bare
MSN surface is negatively charged (37 mV) due to the surface
silanol groups.10 Modifying the MSN surface with a negatively
charged E-PA did not signicantly aﬀect the zeta potential of the
surface (38 mV) since both silanol and E-PA groups are
negatively charged. Coating the MSN surface with a positively
charged K-PA, on the other hand, resulted in a remarkable
increase in the zeta potential (25 mV).Cyto-compatibility of MSNs
A good compatibility of therapeutic nanoparticles with biolog-
ical organisms is necessary to prevent possible side eﬀects ofFig. 4 Cytotoxicity results of bare and peptide functionalized MSNs.
(a) A10 cells incubated for 4 h with particles and 20 h in particle free
media and (b) HUVEC cells incubated for 4 h with particles and 20 h in
particle free media.
2172 | J. Mater. Chem. B, 2014, 2, 2168–2174these therapies. Accordingly, the in vitro cytocompatibilities of
the peptide coated and bare MSNs were evaluated by using
HUVEC and A10 cell lines. The viability of the cells treated with
diﬀerent particle concentrations (10 to 200 mg mL1) was
studied by using the Alamar blue assay. First, cells were treated
with particles for 4 h and then incubated for additional 20 h in
particle free media. None of the particles showed decrease in
the viability of both cell lines even at a very high particle
concentration of 200 mg mL1 (Fig. 4a and b).Cellular uptake studies
Improving the cellular uptake of the therapeutic nanoparticles
is essential for enhancing their eﬃcacy. Therefore, we studied
the uptake of the particles by A10 cells and HUVEC by using
confocal microscopy and ow cytometry techniques. Both A10
cells and HUVEC were treated with 200 mg mL1 nanoparticles
for 4 h and the cells were analyzed aer 20 h of further incu-
bation. As shown in Fig. 5, confocal microscopy revealed that
the peptide coated particles were internalized remarkably more
than the bare MSNs by both cell lines.
In order to compare the uptake amount of the particles, the
uorescence of the internalized particles was quantied by
using a ow cytometer (Fig. 6). More uptake was observed for
K-OMSNs in both cell lines. The amount of internalized uo-
rescent E-OMSNs was less than that of K-OMSNs, however, they
were internalized more than bare particles. The uptake of
K-OMSNs by A10 cells and HUVEC was 2.3 and 6.3 fold larger
than the uptake of MSNs, respectively. Also, E-OMSNs demon-
strated 1.8 and 3.1 fold increased uptake by A10 cells andFig. 5 Uptake results of bare and peptide functionalized MSNs.
Confocal results showing that peptide functionalized particles were
internalized more both A10 and HUVEC cell lines. Upper images at left
show the ﬂuorescence of particles, lower images at left show the
ﬂuorescence of actin ﬁlaments stained by Phalloidin-TRITC and panels
on right show the merged images.
This journal is © The Royal Society of Chemistry 2014
Fig. 6 Flow cytometry analysis of A10 cells and HUVECs treated with
bare and peptide functionalized MSNs. (a) Flow cytometry histograms.
(b) Graph demonstrates the improved uptake of peptide functionalized
MSNs. Data were generated from at least three independent experi-
ments. According to Student's t-test, **p < 0.001 and ***p < 0.0001.
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View Article OnlineHUVEC, respectively, compared to bare MSNs. It is well known
that positively charged surfaces can electrostatically interact
with the slightly negatively charged cell membrane.42 Therefore,
the highest cellular internalization was observed for positively
charged K-PA functionalized K-OMSNs. Although, both MSN
and E-OMSN samples have about the same zeta potential
values, around 40 mV, the cellular uptake of E-OMSNs was
signicantly higher than that of the MSNs. This observation
indicates that the uptake rate and the amount of the nano-
particles cannot be simply correlated with the net surface
charge of the surface; instead, it is more related to the chemical
structure of the surface functional groups.Conclusions
In summary, we developed a straightforward method to func-
tionalize MSNs with short peptide chains by using self-assembly
of PAs around the hydrophobic MSNs. The resulting peptide
functionalized particles can be easily dispersed in the aqueous
media. We observed that peptide functionalized MSNs are not
toxic to the A10 cells and HUVEC up to a high dose of 100 mg
mL1. In addition, it was observed that the cellular uptake of
MSNs can be enhanced up to 6.3 fold by coating them with PAs,
especially positively charged ones. We believe that the facile
method demonstrated in this study can be applied to prepare
MSNs with diverse functionalities including cancer cell target-
ing, cell penetrating properties and responsive drug release, by
simply changing the peptide signal to achieve selective bioactive
properties.This journal is © The Royal Society of Chemistry 2014Acknowledgements
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